NCT06869343 Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
| NCT ID | NCT06869343 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Virginia |
| Condition | Orthopedic Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-05-19 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-05-19 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Proximal humerus fractures can be a debilitating injury in the elderly, impacting the ability to function independently or complete activities of daily living due to pain and restricted shoulder motion. Evidence has shown that reverse total shoulder arthroplasty (rTSA) is an effective option to improve pain and function for patients with acute displaced proximal humerus fractures. Given that patients undergoing rTSA for proximal humerus fractures typically experience worse functional outcomes, worse patient-reported outcomes, and higher rates of complication compared to those with elective indications for surgical intervention, it is critical to determine a secure path to recovery for these patients after surgery. Early rehabilitation has been proposed to be safe and effective for patients who undergo rTSA for elective indications; however, there is a paucity of research evaluating safety and effectiveness of timing of rehabilitation for rTSA patients in the trauma setting. Currently, there exists a great variability in postoperative rehabilitation protocols across orthopaedic practices. This study's objective is to determine the safety and effectiveness of early postoperative rehabilitation on the outcomes and postoperative complications of patients undergoing rTSA for proximal humerus fractures in order to provide more specific recommendations for this patient population.
Eligibility Criteria
Inclusion Criteria: * aged 50-85 undergo reverse Total Shoulder Arthroplasty by a single surgeon for proximal humerus fractures Exclusion Criteria: * previous rTSA to ipsilateral shoulder * undergoing elective rTSA * Prisoners * unwilling to be randomized * unwilling or unable to attend follow up visits
Contact & Investigator
Seth Yarboro, MD
PRINCIPAL INVESTIGATOR
University of Virginia
Frequently Asked Questions
Who can join the NCT06869343 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Orthopedic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06869343 currently recruiting?
Yes, NCT06869343 is actively recruiting participants. Contact the research team at LJE5U@uvahealth.org for enrollment information.
Where is the NCT06869343 trial being conducted?
This trial is being conducted at Charlottesville, United States.
Who is sponsoring the NCT06869343 clinical trial?
NCT06869343 is sponsored by University of Virginia. The principal investigator is Seth Yarboro, MD at University of Virginia. The trial plans to enroll 10 participants.